Medical Devices & Consumables
Cancer Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 558288
- Pages: 138
- Figures: 253
- Views: 1
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
The global market for Cancer Biomarker was estimated to be worth US$ 19580 million in 2023 and is forecast to a readjusted size of US$ 42170 million by 2030 with a CAGR of 11.4% during the forecast period 2024-2030
North American market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Cancer Biomarker include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA and Merck & Co., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Biomarker, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cancer Biomarker by region & country, by Type, and by Application.
The Cancer Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biomarker.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Segment by Type:
Protein Biomarker
Genetic Biomarker
Segment by Application
Diagnostics
Research
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cancer Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cancer Biomarker in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Cancer Biomarker was estimated to be worth US$ 19580 million in 2023 and is forecast to a readjusted size of US$ 42170 million by 2030 with a CAGR of 11.4% during the forecast period 2024-2030
North American market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Cancer Biomarker was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Cancer Biomarker include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA and Merck & Co., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Biomarker, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cancer Biomarker by region & country, by Type, and by Application.
The Cancer Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biomarker.
Market Segmentation
By Company
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Segment by Type:
Protein Biomarker
Genetic Biomarker
Segment by Application
Diagnostics
Research
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cancer Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cancer Biomarker in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Cancer Biomarker Product Introduction
1.2 Global Cancer Biomarker Market Size Forecast
1.2.1 Global Cancer Biomarker Sales Value (2019-2030)
1.2.2 Global Cancer Biomarker Sales Volume (2019-2030)
1.2.3 Global Cancer Biomarker Sales Price (2019-2030)
1.3 Cancer Biomarker Market Trends & Drivers
1.3.1 Cancer Biomarker Industry Trends
1.3.2 Cancer Biomarker Market Drivers & Opportunity
1.3.3 Cancer Biomarker Market Challenges
1.3.4 Cancer Biomarker Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cancer Biomarker Players Revenue Ranking (2023)
2.2 Global Cancer Biomarker Revenue by Company (2019-2024)
2.3 Global Cancer Biomarker Players Sales Volume Ranking (2023)
2.4 Global Cancer Biomarker Sales Volume by Company Players (2019-2024)
2.5 Global Cancer Biomarker Average Price by Company (2019-2024)
2.6 Key Manufacturers Cancer Biomarker Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cancer Biomarker Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cancer Biomarker
2.9 Cancer Biomarker Market Competitive Analysis
2.9.1 Cancer Biomarker Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cancer Biomarker Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Protein Biomarker
3.1.2 Genetic Biomarker
3.2 Global Cancer Biomarker Sales Value by Type
3.2.1 Global Cancer Biomarker Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cancer Biomarker Sales Value, by Type (2019-2030)
3.2.3 Global Cancer Biomarker Sales Value, by Type (%) (2019-2030)
3.3 Global Cancer Biomarker Sales Volume by Type
3.3.1 Global Cancer Biomarker Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cancer Biomarker Sales Volume, by Type (2019-2030)
3.3.3 Global Cancer Biomarker Sales Volume, by Type (%) (2019-2030)
3.4 Global Cancer Biomarker Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostics
4.1.2 Research
4.1.3 Others
4.2 Global Cancer Biomarker Sales Value by Application
4.2.1 Global Cancer Biomarker Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cancer Biomarker Sales Value, by Application (2019-2030)
4.2.3 Global Cancer Biomarker Sales Value, by Application (%) (2019-2030)
4.3 Global Cancer Biomarker Sales Volume by Application
4.3.1 Global Cancer Biomarker Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cancer Biomarker Sales Volume, by Application (2019-2030)
4.3.3 Global Cancer Biomarker Sales Volume, by Application (%) (2019-2030)
4.4 Global Cancer Biomarker Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cancer Biomarker Sales Value by Region
5.1.1 Global Cancer Biomarker Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cancer Biomarker Sales Value by Region (2019-2024)
5.1.3 Global Cancer Biomarker Sales Value by Region (2025-2030)
5.1.4 Global Cancer Biomarker Sales Value by Region (%), (2019-2030)
5.2 Global Cancer Biomarker Sales Volume by Region
5.2.1 Global Cancer Biomarker Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cancer Biomarker Sales Volume by Region (2019-2024)
5.2.3 Global Cancer Biomarker Sales Volume by Region (2025-2030)
5.2.4 Global Cancer Biomarker Sales Volume by Region (%), (2019-2030)
5.3 Global Cancer Biomarker Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cancer Biomarker Sales Value, 2019-2030
5.4.2 North America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cancer Biomarker Sales Value, 2019-2030
5.5.2 Europe Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cancer Biomarker Sales Value, 2019-2030
5.6.2 Asia Pacific Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cancer Biomarker Sales Value, 2019-2030
5.7.2 South America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cancer Biomarker Sales Value, 2019-2030
5.8.2 Middle East & Africa Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cancer Biomarker Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cancer Biomarker Sales Value
6.2.1 Key Countries/Regions Cancer Biomarker Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cancer Biomarker Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cancer Biomarker Sales Value, 2019-2030
6.3.2 United States Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cancer Biomarker Sales Value, 2019-2030
6.4.2 Europe Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cancer Biomarker Sales Value, 2019-2030
6.5.2 China Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cancer Biomarker Sales Value, 2019-2030
6.6.2 Japan Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cancer Biomarker Sales Value, 2019-2030
6.7.2 South Korea Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cancer Biomarker Sales Value, 2019-2030
6.8.2 Southeast Asia Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cancer Biomarker Sales Value, 2019-2030
6.9.2 India Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cancer Biomarker Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Cancer Biomarker Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Information
7.2.2 Bio-Rad Laboratories Introduction and Business Overview
7.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bio-Rad Laboratories Cancer Biomarker Product Offerings
7.2.5 Bio-Rad Laboratories Recent Development
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Information
7.3.2 Roche Diagnostics Introduction and Business Overview
7.3.3 Roche Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Diagnostics Cancer Biomarker Product Offerings
7.3.5 Roche Diagnostics Recent Development
7.4 Qiagen
7.4.1 Qiagen Company Information
7.4.2 Qiagen Introduction and Business Overview
7.4.3 Qiagen Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Qiagen Cancer Biomarker Product Offerings
7.4.5 Qiagen Recent Development
7.5 Illumina
7.5.1 Illumina Company Information
7.5.2 Illumina Introduction and Business Overview
7.5.3 Illumina Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Illumina Cancer Biomarker Product Offerings
7.5.5 Illumina Recent Development
7.6 GE Healthcare
7.6.1 GE Healthcare Company Information
7.6.2 GE Healthcare Introduction and Business Overview
7.6.3 GE Healthcare Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GE Healthcare Cancer Biomarker Product Offerings
7.6.5 GE Healthcare Recent Development
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Information
7.7.2 Agilent Technologies Introduction and Business Overview
7.7.3 Agilent Technologies Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Agilent Technologies Cancer Biomarker Product Offerings
7.7.5 Agilent Technologies Recent Development
7.8 Biomérieux SA
7.8.1 Biomérieux SA Company Information
7.8.2 Biomérieux SA Introduction and Business Overview
7.8.3 Biomérieux SA Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Biomérieux SA Cancer Biomarker Product Offerings
7.8.5 Biomérieux SA Recent Development
7.9 Merck & Co.
7.9.1 Merck & Co. Company Information
7.9.2 Merck & Co. Introduction and Business Overview
7.9.3 Merck & Co. Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck & Co. Cancer Biomarker Product Offerings
7.9.5 Merck & Co. Recent Development
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Information
7.10.2 Abbott Laboratories Introduction and Business Overview
7.10.3 Abbott Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Abbott Laboratories Cancer Biomarker Product Offerings
7.10.5 Abbott Laboratories Recent Development
7.11 Becton, Dickinson and Company
7.11.1 Becton, Dickinson and Company Company Information
7.11.2 Becton, Dickinson and Company Introduction and Business Overview
7.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Becton, Dickinson and Company Cancer Biomarker Product Offerings
7.11.5 Becton, Dickinson and Company Recent Development
7.12 Danaher Corporation
7.12.1 Danaher Corporation Company Information
7.12.2 Danaher Corporation Introduction and Business Overview
7.12.3 Danaher Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Danaher Corporation Cancer Biomarker Product Offerings
7.12.5 Danaher Corporation Recent Development
7.13 Myriad Genetics
7.13.1 Myriad Genetics Company Information
7.13.2 Myriad Genetics Introduction and Business Overview
7.13.3 Myriad Genetics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Myriad Genetics Cancer Biomarker Product Offerings
7.13.5 Myriad Genetics Recent Development
7.14 Sysmex Corporation
7.14.1 Sysmex Corporation Company Information
7.14.2 Sysmex Corporation Introduction and Business Overview
7.14.3 Sysmex Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sysmex Corporation Cancer Biomarker Product Offerings
7.14.5 Sysmex Corporation Recent Development
7.15 Hologic
7.15.1 Hologic Company Information
7.15.2 Hologic Introduction and Business Overview
7.15.3 Hologic Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hologic Cancer Biomarker Product Offerings
7.15.5 Hologic Recent Development
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Company Information
7.16.2 Quest Diagnostics Introduction and Business Overview
7.16.3 Quest Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Quest Diagnostics Cancer Biomarker Product Offerings
7.16.5 Quest Diagnostics Recent Development
8 Industry Chain Analysis
8.1 Cancer Biomarker Industrial Chain
8.2 Cancer Biomarker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cancer Biomarker Sales Model
8.5.2 Sales Channel
8.5.3 Cancer Biomarker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Cancer Biomarker Product Introduction
1.2 Global Cancer Biomarker Market Size Forecast
1.2.1 Global Cancer Biomarker Sales Value (2019-2030)
1.2.2 Global Cancer Biomarker Sales Volume (2019-2030)
1.2.3 Global Cancer Biomarker Sales Price (2019-2030)
1.3 Cancer Biomarker Market Trends & Drivers
1.3.1 Cancer Biomarker Industry Trends
1.3.2 Cancer Biomarker Market Drivers & Opportunity
1.3.3 Cancer Biomarker Market Challenges
1.3.4 Cancer Biomarker Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cancer Biomarker Players Revenue Ranking (2023)
2.2 Global Cancer Biomarker Revenue by Company (2019-2024)
2.3 Global Cancer Biomarker Players Sales Volume Ranking (2023)
2.4 Global Cancer Biomarker Sales Volume by Company Players (2019-2024)
2.5 Global Cancer Biomarker Average Price by Company (2019-2024)
2.6 Key Manufacturers Cancer Biomarker Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cancer Biomarker Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cancer Biomarker
2.9 Cancer Biomarker Market Competitive Analysis
2.9.1 Cancer Biomarker Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cancer Biomarker Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Protein Biomarker
3.1.2 Genetic Biomarker
3.2 Global Cancer Biomarker Sales Value by Type
3.2.1 Global Cancer Biomarker Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cancer Biomarker Sales Value, by Type (2019-2030)
3.2.3 Global Cancer Biomarker Sales Value, by Type (%) (2019-2030)
3.3 Global Cancer Biomarker Sales Volume by Type
3.3.1 Global Cancer Biomarker Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cancer Biomarker Sales Volume, by Type (2019-2030)
3.3.3 Global Cancer Biomarker Sales Volume, by Type (%) (2019-2030)
3.4 Global Cancer Biomarker Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostics
4.1.2 Research
4.1.3 Others
4.2 Global Cancer Biomarker Sales Value by Application
4.2.1 Global Cancer Biomarker Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cancer Biomarker Sales Value, by Application (2019-2030)
4.2.3 Global Cancer Biomarker Sales Value, by Application (%) (2019-2030)
4.3 Global Cancer Biomarker Sales Volume by Application
4.3.1 Global Cancer Biomarker Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cancer Biomarker Sales Volume, by Application (2019-2030)
4.3.3 Global Cancer Biomarker Sales Volume, by Application (%) (2019-2030)
4.4 Global Cancer Biomarker Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cancer Biomarker Sales Value by Region
5.1.1 Global Cancer Biomarker Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cancer Biomarker Sales Value by Region (2019-2024)
5.1.3 Global Cancer Biomarker Sales Value by Region (2025-2030)
5.1.4 Global Cancer Biomarker Sales Value by Region (%), (2019-2030)
5.2 Global Cancer Biomarker Sales Volume by Region
5.2.1 Global Cancer Biomarker Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cancer Biomarker Sales Volume by Region (2019-2024)
5.2.3 Global Cancer Biomarker Sales Volume by Region (2025-2030)
5.2.4 Global Cancer Biomarker Sales Volume by Region (%), (2019-2030)
5.3 Global Cancer Biomarker Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cancer Biomarker Sales Value, 2019-2030
5.4.2 North America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cancer Biomarker Sales Value, 2019-2030
5.5.2 Europe Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cancer Biomarker Sales Value, 2019-2030
5.6.2 Asia Pacific Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cancer Biomarker Sales Value, 2019-2030
5.7.2 South America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cancer Biomarker Sales Value, 2019-2030
5.8.2 Middle East & Africa Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cancer Biomarker Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cancer Biomarker Sales Value
6.2.1 Key Countries/Regions Cancer Biomarker Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cancer Biomarker Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cancer Biomarker Sales Value, 2019-2030
6.3.2 United States Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cancer Biomarker Sales Value, 2019-2030
6.4.2 Europe Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cancer Biomarker Sales Value, 2019-2030
6.5.2 China Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cancer Biomarker Sales Value, 2019-2030
6.6.2 Japan Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cancer Biomarker Sales Value, 2019-2030
6.7.2 South Korea Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cancer Biomarker Sales Value, 2019-2030
6.8.2 Southeast Asia Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cancer Biomarker Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cancer Biomarker Sales Value, 2019-2030
6.9.2 India Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cancer Biomarker Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Cancer Biomarker Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Information
7.2.2 Bio-Rad Laboratories Introduction and Business Overview
7.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bio-Rad Laboratories Cancer Biomarker Product Offerings
7.2.5 Bio-Rad Laboratories Recent Development
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Information
7.3.2 Roche Diagnostics Introduction and Business Overview
7.3.3 Roche Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Diagnostics Cancer Biomarker Product Offerings
7.3.5 Roche Diagnostics Recent Development
7.4 Qiagen
7.4.1 Qiagen Company Information
7.4.2 Qiagen Introduction and Business Overview
7.4.3 Qiagen Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Qiagen Cancer Biomarker Product Offerings
7.4.5 Qiagen Recent Development
7.5 Illumina
7.5.1 Illumina Company Information
7.5.2 Illumina Introduction and Business Overview
7.5.3 Illumina Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Illumina Cancer Biomarker Product Offerings
7.5.5 Illumina Recent Development
7.6 GE Healthcare
7.6.1 GE Healthcare Company Information
7.6.2 GE Healthcare Introduction and Business Overview
7.6.3 GE Healthcare Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GE Healthcare Cancer Biomarker Product Offerings
7.6.5 GE Healthcare Recent Development
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Information
7.7.2 Agilent Technologies Introduction and Business Overview
7.7.3 Agilent Technologies Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Agilent Technologies Cancer Biomarker Product Offerings
7.7.5 Agilent Technologies Recent Development
7.8 Biomérieux SA
7.8.1 Biomérieux SA Company Information
7.8.2 Biomérieux SA Introduction and Business Overview
7.8.3 Biomérieux SA Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Biomérieux SA Cancer Biomarker Product Offerings
7.8.5 Biomérieux SA Recent Development
7.9 Merck & Co.
7.9.1 Merck & Co. Company Information
7.9.2 Merck & Co. Introduction and Business Overview
7.9.3 Merck & Co. Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Merck & Co. Cancer Biomarker Product Offerings
7.9.5 Merck & Co. Recent Development
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Company Information
7.10.2 Abbott Laboratories Introduction and Business Overview
7.10.3 Abbott Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Abbott Laboratories Cancer Biomarker Product Offerings
7.10.5 Abbott Laboratories Recent Development
7.11 Becton, Dickinson and Company
7.11.1 Becton, Dickinson and Company Company Information
7.11.2 Becton, Dickinson and Company Introduction and Business Overview
7.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Becton, Dickinson and Company Cancer Biomarker Product Offerings
7.11.5 Becton, Dickinson and Company Recent Development
7.12 Danaher Corporation
7.12.1 Danaher Corporation Company Information
7.12.2 Danaher Corporation Introduction and Business Overview
7.12.3 Danaher Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Danaher Corporation Cancer Biomarker Product Offerings
7.12.5 Danaher Corporation Recent Development
7.13 Myriad Genetics
7.13.1 Myriad Genetics Company Information
7.13.2 Myriad Genetics Introduction and Business Overview
7.13.3 Myriad Genetics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Myriad Genetics Cancer Biomarker Product Offerings
7.13.5 Myriad Genetics Recent Development
7.14 Sysmex Corporation
7.14.1 Sysmex Corporation Company Information
7.14.2 Sysmex Corporation Introduction and Business Overview
7.14.3 Sysmex Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sysmex Corporation Cancer Biomarker Product Offerings
7.14.5 Sysmex Corporation Recent Development
7.15 Hologic
7.15.1 Hologic Company Information
7.15.2 Hologic Introduction and Business Overview
7.15.3 Hologic Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Hologic Cancer Biomarker Product Offerings
7.15.5 Hologic Recent Development
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Company Information
7.16.2 Quest Diagnostics Introduction and Business Overview
7.16.3 Quest Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Quest Diagnostics Cancer Biomarker Product Offerings
7.16.5 Quest Diagnostics Recent Development
8 Industry Chain Analysis
8.1 Cancer Biomarker Industrial Chain
8.2 Cancer Biomarker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cancer Biomarker Sales Model
8.5.2 Sales Channel
8.5.3 Cancer Biomarker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cancer Biomarker Market Trends
Table 2. Cancer Biomarker Market Drivers & Opportunity
Table 3. Cancer Biomarker Market Challenges
Table 4. Cancer Biomarker Market Restraints
Table 5. Global Cancer Biomarker Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Biomarker Revenue Market Share by Company (2019-2024)
Table 7. Global Cancer Biomarker Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Cancer Biomarker Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cancer Biomarker Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Cancer Biomarker Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cancer Biomarker Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cancer Biomarker
Table 13. Global Cancer Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Biomarker Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cancer Biomarker Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cancer Biomarker Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cancer Biomarker Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cancer Biomarker Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cancer Biomarker Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Cancer Biomarker Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Cancer Biomarker Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Cancer Biomarker Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cancer Biomarker Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cancer Biomarker Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Cancer Biomarker Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Cancer Biomarker Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cancer Biomarker Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Biomarker Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Biomarker Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cancer Biomarker Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cancer Biomarker Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Cancer Biomarker Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Cancer Biomarker Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Cancer Biomarker Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cancer Biomarker Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cancer Biomarker Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Cancer Biomarker Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Cancer Biomarker Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cancer Biomarker Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cancer Biomarker Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cancer Biomarker Sales Value by Region (2019-2024) & (%)
Table 44. Global Cancer Biomarker Sales Value by Region (2025-2030) & (%)
Table 45. Global Cancer Biomarker Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Cancer Biomarker Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Cancer Biomarker Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Cancer Biomarker Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cancer Biomarker Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cancer Biomarker Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Cancer Biomarker Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Cancer Biomarker Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cancer Biomarker Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cancer Biomarker Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cancer Biomarker Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Cancer Biomarker Sales Volume, (2025-2030) & (K Units)
Table 57. Thermo Fisher Scientific Company Information
Table 58. Thermo Fisher Scientific Introduction and Business Overview
Table 59. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Thermo Fisher Scientific Cancer Biomarker Product Offerings
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Bio-Rad Laboratories Company Information
Table 63. Bio-Rad Laboratories Introduction and Business Overview
Table 64. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Bio-Rad Laboratories Cancer Biomarker Product Offerings
Table 66. Bio-Rad Laboratories Recent Development
Table 67. Roche Diagnostics Company Information
Table 68. Roche Diagnostics Introduction and Business Overview
Table 69. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Roche Diagnostics Cancer Biomarker Product Offerings
Table 71. Roche Diagnostics Recent Development
Table 72. Qiagen Company Information
Table 73. Qiagen Introduction and Business Overview
Table 74. Qiagen Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Qiagen Cancer Biomarker Product Offerings
Table 76. Qiagen Recent Development
Table 77. Illumina Company Information
Table 78. Illumina Introduction and Business Overview
Table 79. Illumina Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Illumina Cancer Biomarker Product Offerings
Table 81. Illumina Recent Development
Table 82. GE Healthcare Company Information
Table 83. GE Healthcare Introduction and Business Overview
Table 84. GE Healthcare Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. GE Healthcare Cancer Biomarker Product Offerings
Table 86. GE Healthcare Recent Development
Table 87. Agilent Technologies Company Information
Table 88. Agilent Technologies Introduction and Business Overview
Table 89. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Agilent Technologies Cancer Biomarker Product Offerings
Table 91. Agilent Technologies Recent Development
Table 92. Biomérieux SA Company Information
Table 93. Biomérieux SA Introduction and Business Overview
Table 94. Biomérieux SA Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Biomérieux SA Cancer Biomarker Product Offerings
Table 96. Biomérieux SA Recent Development
Table 97. Merck & Co. Company Information
Table 98. Merck & Co. Introduction and Business Overview
Table 99. Merck & Co. Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Merck & Co. Cancer Biomarker Product Offerings
Table 101. Merck & Co. Recent Development
Table 102. Abbott Laboratories Company Information
Table 103. Abbott Laboratories Introduction and Business Overview
Table 104. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Abbott Laboratories Cancer Biomarker Product Offerings
Table 106. Abbott Laboratories Recent Development
Table 107. Becton, Dickinson and Company Company Information
Table 108. Becton, Dickinson and Company Introduction and Business Overview
Table 109. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Becton, Dickinson and Company Cancer Biomarker Product Offerings
Table 111. Becton, Dickinson and Company Recent Development
Table 112. Danaher Corporation Company Information
Table 113. Danaher Corporation Introduction and Business Overview
Table 114. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Danaher Corporation Cancer Biomarker Product Offerings
Table 116. Danaher Corporation Recent Development
Table 117. Myriad Genetics Company Information
Table 118. Myriad Genetics Introduction and Business Overview
Table 119. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Myriad Genetics Cancer Biomarker Product Offerings
Table 121. Myriad Genetics Recent Development
Table 122. Sysmex Corporation Company Information
Table 123. Sysmex Corporation Introduction and Business Overview
Table 124. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Sysmex Corporation Cancer Biomarker Product Offerings
Table 126. Sysmex Corporation Recent Development
Table 127. Hologic Company Information
Table 128. Hologic Introduction and Business Overview
Table 129. Hologic Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Hologic Cancer Biomarker Product Offerings
Table 131. Hologic Recent Development
Table 132. Quest Diagnostics Company Information
Table 133. Quest Diagnostics Introduction and Business Overview
Table 134. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Quest Diagnostics Cancer Biomarker Product Offerings
Table 136. Quest Diagnostics Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Cancer Biomarker Downstream Customers
Table 140. Cancer Biomarker Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Biomarker Product Picture
Figure 2. Global Cancer Biomarker Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cancer Biomarker Sales Volume (2019-2030) & (K Units)
Figure 5. Global Cancer Biomarker Sales Price (2019-2030) & (USD/Unit)
Figure 6. Cancer Biomarker Report Years Considered
Figure 7. Global Cancer Biomarker Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cancer Biomarker Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Biomarker Revenue in 2023
Figure 10. Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Protein Biomarker Picture
Figure 12. Genetic Biomarker Picture
Figure 13. Global Cancer Biomarker Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cancer Biomarker Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Cancer Biomarker Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Cancer Biomarker Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Cancer Biomarker Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Diagnostics
Figure 19. Product Picture of Research
Figure 20. Product Picture of Others
Figure 21. Global Cancer Biomarker Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Cancer Biomarker Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Cancer Biomarker Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Cancer Biomarker Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Cancer Biomarker Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Cancer Biomarker Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Cancer Biomarker Sales Volume (%), (2019-2030)
Figure 38. United States Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 44. China Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 46. China Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 56. India Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 58. India Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 59. Cancer Biomarker Industrial Chain
Figure 60. Cancer Biomarker Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Cancer Biomarker Market Trends
Table 2. Cancer Biomarker Market Drivers & Opportunity
Table 3. Cancer Biomarker Market Challenges
Table 4. Cancer Biomarker Market Restraints
Table 5. Global Cancer Biomarker Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Biomarker Revenue Market Share by Company (2019-2024)
Table 7. Global Cancer Biomarker Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Cancer Biomarker Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cancer Biomarker Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Cancer Biomarker Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cancer Biomarker Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cancer Biomarker
Table 13. Global Cancer Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Biomarker Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cancer Biomarker Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cancer Biomarker Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cancer Biomarker Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cancer Biomarker Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cancer Biomarker Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Cancer Biomarker Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Cancer Biomarker Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Cancer Biomarker Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cancer Biomarker Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cancer Biomarker Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Cancer Biomarker Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Cancer Biomarker Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cancer Biomarker Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Biomarker Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Biomarker Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cancer Biomarker Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cancer Biomarker Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Cancer Biomarker Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Cancer Biomarker Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Cancer Biomarker Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cancer Biomarker Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cancer Biomarker Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Cancer Biomarker Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Cancer Biomarker Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cancer Biomarker Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cancer Biomarker Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cancer Biomarker Sales Value by Region (2019-2024) & (%)
Table 44. Global Cancer Biomarker Sales Value by Region (2025-2030) & (%)
Table 45. Global Cancer Biomarker Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Cancer Biomarker Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Cancer Biomarker Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Cancer Biomarker Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cancer Biomarker Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cancer Biomarker Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Cancer Biomarker Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Cancer Biomarker Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cancer Biomarker Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cancer Biomarker Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cancer Biomarker Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Cancer Biomarker Sales Volume, (2025-2030) & (K Units)
Table 57. Thermo Fisher Scientific Company Information
Table 58. Thermo Fisher Scientific Introduction and Business Overview
Table 59. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Thermo Fisher Scientific Cancer Biomarker Product Offerings
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Bio-Rad Laboratories Company Information
Table 63. Bio-Rad Laboratories Introduction and Business Overview
Table 64. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Bio-Rad Laboratories Cancer Biomarker Product Offerings
Table 66. Bio-Rad Laboratories Recent Development
Table 67. Roche Diagnostics Company Information
Table 68. Roche Diagnostics Introduction and Business Overview
Table 69. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Roche Diagnostics Cancer Biomarker Product Offerings
Table 71. Roche Diagnostics Recent Development
Table 72. Qiagen Company Information
Table 73. Qiagen Introduction and Business Overview
Table 74. Qiagen Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Qiagen Cancer Biomarker Product Offerings
Table 76. Qiagen Recent Development
Table 77. Illumina Company Information
Table 78. Illumina Introduction and Business Overview
Table 79. Illumina Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Illumina Cancer Biomarker Product Offerings
Table 81. Illumina Recent Development
Table 82. GE Healthcare Company Information
Table 83. GE Healthcare Introduction and Business Overview
Table 84. GE Healthcare Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. GE Healthcare Cancer Biomarker Product Offerings
Table 86. GE Healthcare Recent Development
Table 87. Agilent Technologies Company Information
Table 88. Agilent Technologies Introduction and Business Overview
Table 89. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Agilent Technologies Cancer Biomarker Product Offerings
Table 91. Agilent Technologies Recent Development
Table 92. Biomérieux SA Company Information
Table 93. Biomérieux SA Introduction and Business Overview
Table 94. Biomérieux SA Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Biomérieux SA Cancer Biomarker Product Offerings
Table 96. Biomérieux SA Recent Development
Table 97. Merck & Co. Company Information
Table 98. Merck & Co. Introduction and Business Overview
Table 99. Merck & Co. Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Merck & Co. Cancer Biomarker Product Offerings
Table 101. Merck & Co. Recent Development
Table 102. Abbott Laboratories Company Information
Table 103. Abbott Laboratories Introduction and Business Overview
Table 104. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Abbott Laboratories Cancer Biomarker Product Offerings
Table 106. Abbott Laboratories Recent Development
Table 107. Becton, Dickinson and Company Company Information
Table 108. Becton, Dickinson and Company Introduction and Business Overview
Table 109. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Becton, Dickinson and Company Cancer Biomarker Product Offerings
Table 111. Becton, Dickinson and Company Recent Development
Table 112. Danaher Corporation Company Information
Table 113. Danaher Corporation Introduction and Business Overview
Table 114. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Danaher Corporation Cancer Biomarker Product Offerings
Table 116. Danaher Corporation Recent Development
Table 117. Myriad Genetics Company Information
Table 118. Myriad Genetics Introduction and Business Overview
Table 119. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Myriad Genetics Cancer Biomarker Product Offerings
Table 121. Myriad Genetics Recent Development
Table 122. Sysmex Corporation Company Information
Table 123. Sysmex Corporation Introduction and Business Overview
Table 124. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Sysmex Corporation Cancer Biomarker Product Offerings
Table 126. Sysmex Corporation Recent Development
Table 127. Hologic Company Information
Table 128. Hologic Introduction and Business Overview
Table 129. Hologic Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Hologic Cancer Biomarker Product Offerings
Table 131. Hologic Recent Development
Table 132. Quest Diagnostics Company Information
Table 133. Quest Diagnostics Introduction and Business Overview
Table 134. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Quest Diagnostics Cancer Biomarker Product Offerings
Table 136. Quest Diagnostics Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Cancer Biomarker Downstream Customers
Table 140. Cancer Biomarker Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Biomarker Product Picture
Figure 2. Global Cancer Biomarker Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cancer Biomarker Sales Volume (2019-2030) & (K Units)
Figure 5. Global Cancer Biomarker Sales Price (2019-2030) & (USD/Unit)
Figure 6. Cancer Biomarker Report Years Considered
Figure 7. Global Cancer Biomarker Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cancer Biomarker Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Biomarker Revenue in 2023
Figure 10. Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Protein Biomarker Picture
Figure 12. Genetic Biomarker Picture
Figure 13. Global Cancer Biomarker Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cancer Biomarker Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Cancer Biomarker Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Cancer Biomarker Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Cancer Biomarker Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Diagnostics
Figure 19. Product Picture of Research
Figure 20. Product Picture of Others
Figure 21. Global Cancer Biomarker Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Cancer Biomarker Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Cancer Biomarker Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Cancer Biomarker Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Cancer Biomarker Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Cancer Biomarker Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Cancer Biomarker Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Cancer Biomarker Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Cancer Biomarker Sales Volume (%), (2019-2030)
Figure 38. United States Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 44. China Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 46. China Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 56. India Cancer Biomarker Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Cancer Biomarker Sales Value by Type (%), 2023 VS 2030
Figure 58. India Cancer Biomarker Sales Value by Application (%), 2023 VS 2030
Figure 59. Cancer Biomarker Industrial Chain
Figure 60. Cancer Biomarker Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232